GlassScriptPhysician profile
Shaun S Daneshgar
NPI 1104934983
$3,807.65
in general payments reported to CMS, 2019-2025
9 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,792 · 2020: $350 · 2021: $75.98 · 2022: $186 · 2023: $50.00 · 2024: $89.43 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $211 · Gift: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.48 |
| Gift | $191.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Purelife, LLC | $3,350.00 | 2019-2025 | |
| Salvin Dental Specialties, INC. | $163.44 | 2019-2021 | |
| Stryker Corporation | $63.43 | 2025 | Vsp System, Vsp Cranial |
| Straumann USA LLC | $57.85 | 2022-2025 | |
| Henry Schein, INC. | $46.47 | 2025 | Nuoss, Allooss Allograft Putty, Ace Surgical Supply |
| Pacira Pharmaceuticals Incorporated | $39.43 | 2024 | Exparel |
| Dentsply Sirona INC | $32.35 | 2025 | Implant Dentistry |
| Kls-Martin L.P. | $29.80 | 2025 | |
| Nobel Biocare USA | $24.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Daneshgar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.